Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of combining flavopiridol and cytarabine with
mitoxantrone in treating patients who have acute leukemia. Drugs used in chemotherapy work in
different ways to stop cancer cells from dividing so they stop growing or die. Combining more
than one drug may kill more cancer cells.